Cargando…

FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis

Breast cancer is the most common cancer in women worldwide and the solid tumor type for which the highest number of drugs have been approved to date. This study examines new drug approvals for breast cancer by the United States Food and Drug Administration (FDA) and the European Medicines Agency (EM...

Descripción completa

Detalles Bibliográficos
Autores principales: Leo, Chandra P., Hentschel, Bettina, Szucs, Thomas D., Leo, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072445/
https://www.ncbi.nlm.nih.gov/pubmed/32069837
http://dx.doi.org/10.3390/cancers12020437